Dr. Alfred V.Krempelhuber
Moderna
Medical Director Germany
Transformation in the role of Medical Affairs following the COVID-19 Pandemic
The COVID-9 pandemic changed the contact patterns and roles internally and externally.
- How did this change the relationship to colleagues and external stakeholders?
- What will change back and what will stay after the pandemic?
- What are the most successful communication strategies?
Sara Korchmaros
AstraZeneca
Global Lead for Data and Analytics, Oncology
Understanding the practical application of technologies such as AL, NLP, ML for Medical Affairs
- Using Artificial Intelligence, machine learning, block-chain and algorithms to uncover disease state opportunities, accelerate and synthesize insights from real world data
- Embracing the power of data and analytics, as well as digital-engagement techniques to maximise patient experience and outcomes
- Using analytics to collect metrics, apply learnings and develop tools for cross-functional use
Natasha Hansjee Altmann
Hoffmann La-Roche
Principal Scientific Communications Director
Tackling Today's Challenges in Medical Education
- Overview of the scientific exchange evolution
- What do HCPs want?
- Where do we go from here?
Dr Bishember Kathuria
Novartis
Global Lead - Digital Transformation, Medical Affairs
Simplification and Standardization: Key to Digital Transformation
- Why majority of digital transformations fail ?
- There is an app for that but do we need it ?
- Simplified and Standardized processes versus new technology
- Take control of digital transformation in medical
Zsuzsanna Devecseri
Sanofi
VP Global Oncology Medical Head
Patient-centric Medical Affairs
- What patient centric outcomes are and how to measure them?
- Changing role of patient in treatment decision making.
- Evolution of the delivery of care and its drivers.
- How to work with effectively with patients/advocacy groups?
As innovation transforms the healthcare sector, science and data are becoming the foundation for pharma to meet its commitments to patients and customers while also realizing commercial opportunities. This imperative is accelerating the emergence of medical affairs as the organization's third strategic pillar, alongside R&D and commercial. Hence, Pronovea is bringing together pharma pioneers and healthcare innovators to discuss and exchange best practices and strategic insights; collaborate to enhance communication strategies; build-out medical affairs teams; get ready for launches; explore various tools to track progress, and keep customers engaged in a digital world.